TXTM (.0004) Let the chase begin... The company is pleased to announced that it has reached an agreement to acquire Plandai Biotechnology South Africa (Plandai SA), a wholly owned subsidiary of Plandai Biotechnolgy, Inc (PLPL). Plandai SA is a biotechnology firm engaged in the research and development of botanical extracts, aimed at treating metabolic disorders, like diabetes & others. The parent company, Plandaí Biotechnology, Inc. is the culmination of over 10 years of R&D in the field of plant extracts with principle holdings including raw materials processing infrastructure, production facilities, farms and land totaling more than 7500 acres, in the province of Mpumalanga, South Africa.
Closing is expected to occur on or around January 2, 2017.
News 
Market Data 
Discover 
